N@N

Spectranetics to Present at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference on December 7

^{Published on 2010-11-30 09:01:24 - Market Wire}
 

COLORADO SPRINGS, Colo.--([ BUSINESS WIRE ])--Spectranetics Corporation (Nasdaq: SPNC) today announced that it will present at the 5^th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference being held December 7-8, 2010 at the Nikko Hotel in San Francisco.

Guy A. Childs, Spectraneticsa™ chief financial officer, is scheduled to speak on Tuesday, December 7^th at 10:30 a.m. Pacific time (1:30 p.m. Eastern time).

Interested parties can access a live audio webcast and slide presentation at [ www.spectranetics.com ]. An archived presentation will be available on the Web site for 14 days.

About Spectranetics

Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Companya™s products are sold in 40 countries throughout the world and are used to treat arterial blockages in the heart and legs as well as the removal of problematic pacemaker and defibrillator leads.

The Companya™s Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration and thrombectomy catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.

The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of problematic pacemaker and defibrillator cardiac leads.

For more information, visit [ www.spectranetics.com ].